Rezultati pretraživanja
  1. prije 2 sata
  2. prije 10 sati

    Okay I think I am bullish on too many biotech names: , , , , , , , , , , , , , , , , , , , Extreme long-shots small pos: Researching:

    Prikaži ovu nit
  3. prije 13 sati

    recently acted as co-manager for on a $65 million transaction. Read more here:

  4. 4. velj

    : New Insider Filing on Director THOMAS G AUCHINCLOSS:

  5. 4. velj
  6. 4. velj

    new insider buying: 1000 shares.

  7. 4. velj

    : Auchincloss Thomas G bought $10,910 in CONCERT PHARMACEUTICALS, INC.

  8. 4. velj
  9. 3. velj
  10. 1. velj

    Concert Pharmaceuticals Lowered to Hold at BidaskClub

  11. 31. sij

    My top longterm 2020 picks: 1Q catalysts & many pipeline validation catalysts next 14 mos, 3 Ph 3 read outs next 1-4 mos & new Ph3s starting, FT-218 Ph3 data soon & SP incorporates very low POS, CTP-543 IP wins & CTP-592 safety-de-risked very high value.

  12. 31. sij
  13. 30. sij
  14. 29. sij

    Concert Pharmaceuticals Rating Reiterated by Mizuho

  15. 29. sij

    Concert Pharmaceuticals Rating Lowered to Sell at Zacks Investment Research

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.